GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Joinn Laboratories (China) Co Ltd (HKSE:06127) » Definitions » PE Ratio (TTM)

Joinn Laboratories (China) Co (HKSE:06127) PE Ratio (TTM) : 114.91 (As of Apr. 03, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Joinn Laboratories (China) Co PE Ratio (TTM)?

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2025-04-03), Joinn Laboratories (China) Co's share price is HK$12.18. Joinn Laboratories (China) Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.11. Therefore, Joinn Laboratories (China) Co's PE Ratio (TTM) for today is 114.91.

Warning Sign:

Joinn Laboratories (China) Co Ltd stock PE Ratio (=203.8) is close to 10-year high of 218.7.


The historical rank and industry rank for Joinn Laboratories (China) Co's PE Ratio (TTM) or its related term are showing as below:

HKSE:06127' s PE Ratio (TTM) Range Over the Past 10 Years
Min: 19.45   Med: 64.14   Max: 218.7
Current: 114.91


During the past 13 years, the highest PE Ratio (TTM) of Joinn Laboratories (China) Co was 218.70. The lowest was 19.45. And the median was 64.14.


HKSE:06127's PE Ratio (TTM) is ranked worse than
95.83% of 96 companies
in the Medical Diagnostics & Research industry
Industry Median: 28.95 vs HKSE:06127: 114.91

Joinn Laboratories (China) Co's Earnings per Share (Diluted) for the three months ended in Dec. 2024 was HK$0.20. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.11.

As of today (2025-04-03), Joinn Laboratories (China) Co's share price is HK$12.18. Joinn Laboratories (China) Co's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.41. Therefore, Joinn Laboratories (China) Co's PE Ratio without NRI for today is 30.00.

During the past 13 years, Joinn Laboratories (China) Co's highest PE Ratio without NRI was 215.05. The lowest was 19.04. And the median was 59.56.

Joinn Laboratories (China) Co's EPS without NRI for the three months ended in Dec. 2024 was HK$0.18. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.41.

During the past 12 months, Joinn Laboratories (China) Co's average EPS without NRI Growth Rate was -93.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was -65.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was -25.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 10.90% per year.

During the past 13 years, Joinn Laboratories (China) Co's highest 3-Year average EPS without NRI Growth Rate was 75.70% per year. The lowest was -65.50% per year. And the median was 29.50% per year.

Joinn Laboratories (China) Co's EPS (Basic) for the three months ended in Dec. 2024 was HK$0.20. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.11.


Joinn Laboratories (China) Co PE Ratio (TTM) Historical Data

The historical data trend for Joinn Laboratories (China) Co's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joinn Laboratories (China) Co PE Ratio (TTM) Chart

Joinn Laboratories (China) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PE Ratio (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 74.41 77.08 29.18 44.74 166.30

Joinn Laboratories (China) Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.74 At Loss 73.72 N/A 166.30

Competitive Comparison of Joinn Laboratories (China) Co's PE Ratio (TTM)

For the Diagnostics & Research subindustry, Joinn Laboratories (China) Co's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Joinn Laboratories (China) Co's PE Ratio (TTM) Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Joinn Laboratories (China) Co's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where Joinn Laboratories (China) Co's PE Ratio (TTM) falls into.


;
;

Joinn Laboratories (China) Co PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Joinn Laboratories (China) Co's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=12.18/0.106
=114.91

Joinn Laboratories (China) Co's Share Price of today is HK$12.18.
Joinn Laboratories (China) Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.11.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Joinn Laboratories (China) Co  (HKSE:06127) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


Joinn Laboratories (China) Co PE Ratio (TTM) Related Terms

Thank you for viewing the detailed overview of Joinn Laboratories (China) Co's PE Ratio (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


Joinn Laboratories (China) Co Business Description

Traded in Other Exchanges
Address
A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.
Executives
Yi Fang Da Ji Jin Guan Li You Xian Gong Si 2102 Investment manager
Futu Trustee Limited 2301 Trustee
Ubs Group Ag 2201 Interest of corporation controlled by you
Aggregate Of Abrdn Plc Affiliated Investment Management Entities 2102 Investment manager
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co. 2502 Approved lending agent
Fidelity Funds 2101 Beneficial owner
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Abrdn Asia Focus Plc 2101 Beneficial owner
Morgan Stanley 2201 Interest of corporation controlled by you
The Goldman Sachs Group, Inc. 2201 Interest of corporation controlled by you
Apg Asset Management N.v. 2101 Beneficial owner
Apg Groep N.v. 2101 Beneficial owner

Joinn Laboratories (China) Co Headlines

No Headlines